Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
CLB Quote, Financials, Valuation and Earnings
Last price:
$16.55
Seasonality move
:
5.95%
Day range:
$16.47 - $16.93
52-week range:
$9.72 - $20.82
Dividend yield:
0.24%
P/E ratio:
24.50x
P/S ratio:
1.52x
P/B ratio:
2.85x
Volume:
407.4K
Avg. volume:
424.8K
1-year change:
-1.54%
Market cap:
$774.3M
Revenue:
$523.8M
EPS (TTM):
$0.68
Analysts' Opinion
-
Consensus RatingCore Laboratories Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $14.00, Core Laboratories Inc. has an estimated downside of -15.61% from its current price of $16.59.
-
Price Target UpsideAccording to analysts, the highest upside price target is $18.00 representing -100% upside increase from its current price of $16.59.
Fair Value
-
According to the consensus of 1 analyst, Core Laboratories Inc. has -15.61% downside to fair value with a price target of $14.00 per share.
CLB vs. S&P 500
-
Over the past 5 trading days, Core Laboratories Inc. has underperformed the S&P 500 by -1.72% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Core Laboratories Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Core Laboratories Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Core Laboratories Inc. reported revenues of $134.5M.
Earnings Growth
-
Core Laboratories Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Core Laboratories Inc. reported earnings per share of $0.30.
Enterprise value:
920M
EV / Invested capital:
2.07x
Price / LTM sales:
1.52x
EV / EBIT:
20.58x
EV / Revenue:
1.78x
PEG ratio (5yr expected):
3.85x
EV / Free cash flow:
26.80x
Price / Operating cash flow:
22.89x
Enterprise value / EBITDA:
15.50x
Gross Profit (TTM):
$88.6M
Return On Assets:
5.5%
Net Income Margin (TTM):
6.33%
Return On Equity:
12.42%
Return On Invested Capital:
7.38%
Operating Margin:
11.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $509.2M | $522.8M | $517.5M | $134.4M | $134.5M | |
| Gross Profit | $94.9M | $91.8M | $88.6M | $23.9M | $26M | |
| Operating Income | $55.6M | $52.5M | $44.7M | $15.3M | $15.3M | |
| EBITDA | $71.6M | $67.6M | $59.4M | $19M | $18.9M | |
| Diluted EPS | $0.87 | $0.64 | $0.68 | $0.25 | $0.30 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $187.2M | $195.2M | $228.5M | $235.2M | $226.9M | |
| Total Assets | $586.3M | $570.2M | $592.4M | $600.5M | $591.4M | |
| Current Liabilities | $93M | $87.4M | $84.3M | $94.9M | $95.7M | |
| Total Liabilities | $425.3M | $386.9M | $363M | $344M | $314M | |
| Total Equity | $161M | $183.3M | $229.5M | $256.4M | $277.4M | |
| Total Debt | $242.3M | $224.7M | $218.8M | $183.6M | $155.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $18.6M | $55.4M | $49.9M | $13.6M | $9M | |
| Cash From Investing | -$3.3M | -$5.2M | -$1.8M | -$530K | $2.5M | |
| Cash From Financing | -$12.5M | -$45.2M | -$43.7M | -$9.2M | -$17.3M | |
| Free Cash Flow | $8.5M | $44M | $34.3M | $10.7M | $5.8M | |
CLB
Sector
Market Cap
$774.3M
$36.2M
Price % of 52-Week High
79.88%
70.17%
Dividend Yield
0.24%
0%
Shareholder Yield
4.16%
0.05%
1-Year Price Total Return
-1.54%
-0.39%
Beta (5-Year)
1.083
0.453
Dividend yield:
0.24%
Annualized payout:
$0.04
Payout ratio:
3.25%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$16.40
200-day SMA
Buy
Level
$12.92
Bollinger Bands (100)
Buy
Level
11.12 - 15.66
Chaikin Money Flow
Buy
Level
44.9M
20-day SMA
Buy
Level
$16.11
Relative Strength Index (RSI14)
Buy
Level
58.61
ADX Line
Buy
Level
20.5
Williams %R
Neutral
Level
-39.8773
50-day SMA
Buy
Level
$15.21
MACD (12, 26)
Buy
Level
0.37
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
58.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2395)
Buy
CA Score
(Annual)
Level (-0.1785)
Buy
Beneish M-Score
(Annual)
Level (-2.5633)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.5943)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. It operates through the Reservoir Description and Production Enhancement segments. The Reservoir Description segment engages in petroleum reservoir analysis for energy. The Production Enhancement segment includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment. The company was founded in 1936 and is headquartered in Houston, TX.
Stock Forecast FAQ
In the current month, CLB has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CLB average analyst price target in the past 3 months is $14.00.
-
Where Will Core Laboratories Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Core Laboratories Inc. share price will drop to $14.00 per share over the next 12 months.
-
What Do Analysts Say About Core Laboratories Inc.?
Analysts are divided on their view about Core Laboratories Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Core Laboratories Inc. is a Sell and believe this share price will rise from its current level to $10.00.
-
What Is Core Laboratories Inc.'s Price Target?
The price target for Core Laboratories Inc. over the next 1-year time period is forecast to be $14.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CLB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Core Laboratories Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of CLB?
You can purchase shares of Core Laboratories Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Core Laboratories Inc. shares.
-
What Is The Core Laboratories Inc. Share Price Today?
Core Laboratories Inc. was last trading at $16.55 per share. This represents the most recent stock quote for Core Laboratories Inc.. Yesterday, Core Laboratories Inc. closed at $16.59 per share.
-
How To Buy Core Laboratories Inc. Stock Online?
In order to purchase Core Laboratories Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CLB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLB
Sector
P/E ratio
24.50x
12.83x
PEG ratio
3.85x
0.00x
P/B ratio
2.85x
0.96x
Price / LTM sales
1.52x
0.95x
Growth Metrics
CLB
Sector
Revenue growth
0.09%
-3.48%
Earnings growth
23.17%
-12.5%
Revenue (5-year growth)
-4.75%
4.93%
Earnings forecast
$0.19
$0.19
Profitability
CLB
Sector
Profitability FY 2024
$88.4M
$15.5M
Return on invested capital
7.38%
1.9%
Return on assets
5.5%
0.61%
Return on equity
12.42%
3.4%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Jan
28
Estimated Next Earnings Date
Jan
21
Balance Sheet
CLB
Sector
Total cash
$25.6M
$10.2M
Short term investments
--
$2.5M
Total assets
$590.4M
$291.1M
Long term debt
$155.6M
$15.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
